Physician profile
Edna S Becht
NPI 1962842872
$1,342.53
in general payments reported to CMS, 2019-2025
13 companies · $504 in 2025
The $504 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $258 · 2024: $581 · 2025: $504.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,343.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,342.53 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $489.61 | 2023-2025 | Ubrelvy, Qulipta |
| Pfizer INC. | $207.54 | 2023-2025 | |
| Lilly USA, LLC | $163.76 | 2023-2025 | Mounjaro, Zepbound, Jardiance |
| Novo Nordisk INC | $136.70 | 2024-2025 | Ozempic, Rybelsus, Wegovy |
| Abbott Laboratories | $93.34 | 2024-2025 | Freestyle Libre 3 |
| Glaxosmithkline, LLC. | $55.76 | 2024-2025 | Trelegy Ellipta, Shingrix |
| Bayer Healthcare Pharmaceuticals INC. | $53.45 | 2023-2024 | |
| Astellas Pharma US INC | $31.46 | 2023 | Veozah |
| Otsuka America Pharmaceutical, INC. | $27.91 | 2024 | Rexulti |
| Insulet Corporation | $27.52 | 2023 | Omnipod |
| Boehringer Ingelheim Pharmaceuticals, INC. | $22.19 | 2023 | Jardiance |
| Merck Sharp & Dohme LLC | $18.70 | 2024 | Gardasil 9, Gardasil, Capvaxive |
| Cranial Technologies, INC | $14.59 | 2025 | Doc Band |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Edna Becht listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.